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CtBP1 Overexpression in Keratinocytes Perturbs Skin
Homeostasis
Hui Deng1,2,3,6, Fulun Li2,4,6, Hong Li1,6, Yu Deng1, Jing Liu1, Donna Wang2, Gangwen Han2,
Xiao-Jing Wang1,2 and Qinghong Zhang1,2,5
Carboxyl-terminal–binding protein-1 (CtBP1) is a transcriptional corepressor with multiple in vitro targets, but its
in vivo functions are largely unknown. We generated keratinocyte-specific CtBP1 transgenic mice with a keratin-5
promoter (K5.CtBP1) to probe the pathological roles of CtBP1. At transgene expression levels comparable to
endogenous CtBP1 in acute skin wounds, the K5.CtBP1 epidermis displayed hyperproliferation, loss of
E-cadherin, and failed terminal differentiation. Known CtBP1 target genes associated with these processes, e.g.,
p21, Brca1, and E-cadherin, were downregulated in K5.CtBP1 skin. Surprisingly, K5.CtBP1 pups also exhibited a hair
loss phenotype. We found that expression of the Distal-less 3 (Dlx3), a critical regulator of hair follicle
differentiation and cycling, was decreased in K5.CtBP1 mice. Molecular studies revealed that CtBP1 directly
suppressed Dlx3 transcription. Consistently, K5.CtBP1 mice displayed abnormal hair follicles with decreased
expression of Dlx3 downstream targets Gata3, Hoxc13, and hair keratins. In summary, this CtBP1 transgenic model
provides in vivo evidence for certain CtBP1 functions predicted from in vitro studies, reveals—to our
knowledge—previously unreported functions and transcriptional activities of CtBP1 in the context of
epithelial–mesenchymal interplay, and suggests that CtBP1 has a pathogenic role in hair follicle morphogenesis
and differentiation.
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INTRODUCTION
CtBP was originally identified on the basis of its ability to bind
with the carboxyl terminus of the E1A oncoprotein (Boyd
et al., 1993; Schaeper et al., 1995). Subsequently, carboxyl-
terminal–binding protein (CtBP) was found as a transcriptional
corepressor involved in a variety of biological processes,
including proliferation and anti-apoptosis (Chinnadurai,
2002). CtBP indirectly binds DNA with various DNA-
binding partners at multiple DNA sequences; thus, CtBP-
mediated transcriptional repression is context-specific. For
instance, CtBP represses E-cadherin in epithelial cells
(Grooteclaes and Frisch, 2000; Grooteclaes et al., 2003;
Zhang et al., 2006), IL-4 in human T cells (Kitamura et al.,
2009), and dll4, sprouty, and ve-cadherin for endothelial
sprouting (Roukens et al., 2010). Recently, we and others
found that CtBP downregulates DNA damage repair by
directly suppressing the transcription of breast cancer type 1
susceptibility protein (Brca1) in cancer cells (Deng et al.,
2010; Di et al., 2010).
In mammals, there are two isoforms, carboxyl-terminal–
binding protein-1 (CtBP1) and CtBP2. Both isoforms are
expressed in the wild-type mouse embryo and have over-
lapping and unique roles (Hildebrand and Soriano, 2002).
CtBP1 knockout mice are small and 23% die of an unknown
cause by 20 days postpartum. CtBP2-null mice are small in
size, have axial truncations, delayed neural, muscular, and
skeletal development, and defects in heart morphogenesis;
they die by E10.5 because of defects in both yolk sac and
placental vascularization. In most human and mouse adult
tissues, CtBP expression is low. Reactivation of CtBP
expression has been shown in pathological conditions, e.g.,
cancer (Nadauld et al., 2006; Deng et al., 2010), but its in vivo
role in adult tissue is virtually unknown.
To determine the effects of aberrant CtBP1 expression in
keratinocytes in vivo, we targeted CtBP1 overexpression to the
basal layer of the epidermis and hair follicle using a keratin-5
promoter (K5.CtBP1) (He et al., 2002). The K5.CtBP1 transge-
nic epidermis displayed loss of E-cadherin, hyperproliferation,
and decreased differentiation. Unexpectedly, K5.CtBP1 mice
also exhibited defective hair morphogenesis starting at postna-
tal stage. Molecular analyses revealed that CtBP1 directly
repressed transcription of the Distal-less 3 (Dlx3) gene, a
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homeobox transcription factor that has a critical role in hair
development by orchestrating the differentiation of the inner
root sheath and hair shaft (Hwang et al., 2008). Supporting this
link, we found a hair follicle formation defect in K5.CtBP1
mice, with decreased expression of Dlx3 and its target genes.
Our study provides in vivo model for CtBP1 overexpression
and reveals that CtBP1 overexpression perturbs epidermal and
hair follicle homeostasis.
RESULTS
Generation of CtBP1 transgenic mice
In normal mouse skin, CtBP1 is barely detectable. Acute skin
wound by punch biopsy induced CtBP1 expression B6-fold
higher than in non-wounded skin (Figure 1a). To evaluate the
role of CtBP1 overexpression in the skin, we generated
K5.CtBP1 transgenic mice by inserting human CtBP1 cDNA
(99% amino acid homology to mouse CtBP1 protein) into a K5
vector (He et al., 2002). Three K5.CtBP1 transgenic founders
(K1, K2, and K3) were generated. Their CtBP1 transgene
expression levels were 7–10-fold higher than that of endogen-
ous CtBP1 but were comparable to wounds at the mRNA level
(Figure 1a). Overall, K5.CtBP1 phenotype severity correlated
with transgene expression levels, suggesting that CtBP1 over-
expression causes the phenotype. Results from the representa-
tive line K2 were shown in this study. K5.CtBP1 pups were
born without gross abnormality (not shown) but began to
exhibit thickened skin at 1 week postpartum when wild-type
mice developed their first coat of hair and K5.CtBP1 pups
had no hair growth (Figure 1b). After weaning, K5.CtBP1 mice
exhibited hair loss on their dorsal and ventricle sides
(Figure 1c). These transgenic mice died between 3 and 6
weeks of age due to severe hyperplasia in the esophagus
(Figure 1d) and forestomach (not shown) where CtBP1 trans-
gene was also expressed, compromising food intake. Compared
with the wild-type control, these K5.CtBP1 mice also displayed
abnormal epithelium in their tongues (Figure 1d).
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Figure 1. Generation of K5.CtBP1 mice and phenotypes. (a) CtBP1 mRNA expression in skin of wild-type (WT) mice and K5.CtBP1 transgenic mice (K1, K2, K3),
and acutely wounded WT skin (wound). The mRNA level in WT skin was arbitrarily set as ‘‘1’’. Error bars indicate SD (n¼ 3); significance was determined
using Student’s t test. **Po0.01; *Po0.05. (b) Hyperplasia/hyperkeratotic gross appearance of a K5.CtBP1 transgenic pup 8 days postpartum, in comparison with
WT littermates. (c) Thin and patchy hair in K5.CtBP1 mice 3 weeks postpartum, in comparison with WT littermates. (d) Hematoxylin and eosin staining of WT and
K5.CtBP1 tongue (top panels) and esophagus (bottom panels). Scale bar¼15mm (top panels) and 40mm (bottom panels).
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K5.CtBP1 mice displayed epidermal hyperproliferation, with
decreased expression of p21 and Brca1
Reactivation of CtBP1 expression has been shown in cancer
(Nadauld et al., 2006; Deng et al., 2010) and during wound
healing (Figure 1a), presumably contributing to the hyper-
proliferative process in these conditions. We biopsied the
K5.CtBP1 skin on day 21 postpartum to examine morphology
changes (Figure 2a) and expression of CtBP1 (Figure 2b and c).
Hyperplasia in the epidermis of transgenic mice became
obvious at the microscopic level (Figure 2a). Although the
K5 promoter targets CtBP1 expression to basal keratinocytes,
nuclear CtBP1 staining was apparent throughout the entire
epidermis and hair follicles in K5.CtBP1 transgenic mice
(Figure 2c), possibly because of protein retention in differ-
entiated layers. In contrast, weak CtBP1 staining was detected
in wild-type skin (Figure 2b and c). Interestingly, although the
CtBP1 transgene is targeted to keratinocytes, CtBP1-positive
cells were also observed in the K5.CtBP1 dermis but not in
wild-type dermis (Figure 2c). This is likely increased endo-
genous CtBP1 in stromal cells in response to changes in the
epidermis and hair follicles. The origin of the cells over-
expressing endogenous CtBP1 in the transgenic dermis
remains to be determined.
In vitro studies show that CtBP1 has both anti-apoptotic and
proliferative effects (Grooteclaes et al., 2003; Mroz et al.,
2008), potentially causing epidermal hyperplasia. Apoptosis,
WT
H
&E
K5.CtBP1
WT
Ct
BP
1
PC
NA
Br
dU
/K
14
K5.CtBP1 1.2
K14
CtBP1
25 kDa
75 kDa
0.8
WT K5.CtBP1
WT
WT
K5.CtBP1
K5
.Ct
BP
1
**
**
p2
1 
ex
pr
es
sio
n
Br
ca
1 
ex
pr
es
sio
n
0.4
0
1.2
1.6
0.8
0.4
0
WT K5.CtBP1
WT K5.CtBP1
Figure 2. Microscopic characteristics of K5.CtBP1 skin. (a) Hematoxylin and eosin (H&E) staining of 21-day-old mice shows hyperplasia of the epidermis in
K5.CtBP1 skin compared with wild-type (WT) skin. (b) Western blotting of CtBP1 in WT and K5.CtBP1 skin. Keratin 14 (K14) was used as loading control.
Immunohistochemistry using antibodies specific for CtBP1 (c) and PCNA (d). Scale bar¼ 40mm (all panels). qRT–PCR analysis shows downregulation of CtBP1
target genes p21 (e) and Brca1 (f) in K5.CtBP1 skins. p21 mRNA was decreased to 0.17±0.09 and Brca1 mRNA was decreased to 0.09±0.03 in transgenic skin.
(g) Keratinocytes from K5.CtBP1 mice displayed an increased BrdU index. Keratin 14 (red) was used as a counterstain. Scale bar¼ 15mm.
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as determined by cleaved Caspase-3, was not changed in
K5.CtBP1 skin (not shown). Proliferative cells, identified by
PCNA staining, were sporadic in the basal layer of the epi-
dermis and hair follicles of wild-type skin, but were expanded
to suprabasal layers of K5.CtBP1 transgenic epidermis and hair
follicles (Figure 2d). Furthermore, we found that mRNA levels
of p21 and Brca1 were decreased in skin with CtBP1 over-
expression, with a 5- and 11-fold reduction, respectively, in
K5.CtBP1 skin compared with control skin (Figure 2e and f),
supporting the notion that CtBP1 positively contributes to
proliferation in keratinocytes. We cultured keratinocytes from
K5.CtBP1 mice. Consistent with the hyperplasic phenotype
observed in K5.CtBP1 mice, keratinocytes derived from these
animals displayed a higher BrdU index than the wild-type
controls (Figure 2g), suggesting that the proliferative property
is cell autonomous. No major difference was detected in the
cell cycle analysis and migration assay (not shown).
CtBP1 transgene expression reduced differentiation and caused
loss of E-cadherin in the epidermis and hair follicles
Previously, we and others showed that CtBP1 represses the
transcription of E-cadherin by directly targeting the E-cadherin
promoter (Grooteclaes and Frisch, 2000; Grooteclaes et al.,
2003; Zhang et al., 2006). To determine whether CtBP1
expression in epithelial cells leads to E-cadherin reduction,
we performed qRT–PCR on K5.CtBP1 skin on day 21 post-
partum and found that E-cadherin mRNA was decreased when
compared with that of wild-type control littermates
(Figure 3a). Consistent with the mRNA decrease, E-cadherin
protein was largely lost in K5.CtBP1 epidermis and hair
follicles as seen by immunostaining (Figure 3b). The E-cad-
herin loss in K5.CtBP1 mice is progressive, as only a small
decrease in E-cadherin was detected in day 1 pup skin
compared with wild-type littermates (not shown).
Next, we examined the epidermal differentiation of
K5.CtBP1 mice. Early epidermal differentiation markers, ker-
atins K1 and K10, were not altered (not shown), but epidermal
terminal differentiation markers loricrin and filaggrin were
largely diminished by immunostaining in the K5.CtBP1 epi-
dermis (Figure 3c) and significantly reduced by western
blotting (Figure 3d). Because CtBP1 is a classic transcriptional
corepressor and potentially contributes to the decreased
differentiation by transcriptional repression of the terminal
differentiation players, we assayed the mRNA levels of loricrin
and filaggrin, important physical barrier components in the
epidermis against the environment (Kalinin et al., 2001; Candi
et al., 2005). Different from the protein loss observed in the
K5.CtBP1 epidermis, neither loricrin nor filaggrin showed a
decrease in their mRNA levels (Figure 3e), suggesting that the
defect in epidermal terminal differentiation is a secondary
effect.
CtBP1 transgene suppressed Dlx3, a critical regulator of hair
follicle differentiation
We biopsied neonatal skin and found no obvious hair follicle
changes at birth (not shown), suggesting that CtBP1 did not
affect hair development. Consistently, similar expression of
LEF-1, b-catenin, and pSmad1/5/8 was detected in the CtBP1
transgenic skin hair follicles (not shown), implying that Wnt
and bone morphogenic protein signaling pathways are not
affected by CtBP1 overexpression in the epidermis. Structural
hair follicle abnormalities were observed by day 9 postpartum.
Hair follicles had formed large hair bulbs and differentiated
hair shafts in wild-type mice. In contrast, CtBP1 transgenic
hair follicles displayed smaller hair bulbs, with reduced
keratinized medulla and defects in the inner root sheath and
hair shaft (Figure 4a), phenotypes reminiscent of hair follicle
abnormities observed in Dlx3-null mice (Hwang et al., 2008).
Therefore, we used the Dlx3 hair follicle differentiation marker
to explore the molecular mechanism associated with hair loss
in K5.CtBP1 mice. On day 9 postpartum, Dlx3 was expressed
in hair matrix cells, inner root sheath, as well as in hair-
forming compartments such as the cortex, medulla, and
cuticle in hair follicles in wild-type mice (Figure 4b, left
panel). However, expression of Dlx3 was largely reduced in
hair follicles in K5.CtBP1 mice (Figure 4b, right panel),
suggesting that CtBP1 overexpression in hair follicles down-
regulates Dlx3 to induce the differentiation defect of the inner
root sheath and hair shaft. Cross-sectional co-immunofluores-
cence staining of Dlx3 and CtBP1 revealed that in wild-type
hair follicles the Dlx3 expression is in the inner root sheath,
with CtBP1 expression mainly in the outer root sheath
(Figure 4c, left panel). In K5.CtBP1 hair follicles, expression
of Dlx3 was decreased, with CtBP1 expansion to the inner
root sheath (Figure 4c, right panel). To evaluate the Dlx3
changes at the mRNA level, in situ hybridization analysis was
performed. Dlx3 mRNA was detected in the wild-type mice
hair follicles (Supplementary Figure S1 online, left panel).
In contrast, there was very little Dlx3 detected in the K5.CtBP1
hair follicles (Supplementary Figure S1 online, right panel).
Next, we assayed the mRNA level of Dlx3 in K5.CtBP1 skin
by qRT–PCR and compared it with that in wild-type litter-
mates. A significant decrease in Dlx3 mRNA was detected in
CtBP1 transgenic skin (Figure 5a). To determine whether
CtBP1 has a direct role in regulation of the Dlx3 gene, we
performed chromatin immunoprecipitation (ChIP) to deter-
mine whether CtBP1 is recruited to the Dlx3 promoter in
mouse keratinocytes. Mouse keratinocytes were transfected
with a vector expressing CtBP1, either wild-type or the
PLDLX-binding deficient mutant tagged with the FLAG epi-
tope, and the cross-linked chromatin was immunoprecipitated
with an anti-FLAG antibody. Wild-type CtBP1 bound the Dlx3
promoter region, whereas the PLDLX-binding deficient mutant
did not (Figure 5b). This binding is limited to the promoter
region, as no signal was detected with PCR amplification
of the ChIP material using primers either 50 or 30 2 kb to the
Dlx3 promoter (Figure 5b). Consistent with mRNA changes
observed during CtBP1 knockdown, the luciferase activity of
the Dlx3 promoter decreased by 60% with CtBP1 overexpres-
sion in mouse keratinocytes (Figure 5c), indicating that CtBP1
regulates Dlx3 transcription, at least partially, by binding to its
promoter. To investigate whether the CtBP1-mediated repres-
sion of Dlx3 gene occurs in human cells, we knocked down
CtBP1 in Fadu cells, a human SCC cell line exhibiting high
endogenous CtBP1 (Deng et al., 2010), and assayed the Dlx3-
luciferase reporter. CtBP1 knockdown increased the Dlx3-luc
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reporter activity (Figure 5d), suggesting that CtBP1’s repressive
role in Dlx3 transcription is conserved between mouse and
human cells.
To further study the functional consequence of CtBP1-
mediated repression of the Dlx3 gene, we examined mRNA
levels of Dlx3 transcriptional targets in K5.CtBP1 skin. Gata3
and Hoxc13 are transcription factors affecting hair differentia-
tion (Godwin and Capecchi, 1998; Kurek et al., 2007).
Decreased Gata3 and Hoxc13 expression was detected in
genetically engineered K14-Dlx3 / mice (Hwang et al.,
2008). As shown in Figure 6a, CtBP1 transgene expression
decreased mRNA levels of Gata3 to 60% of those seen in
control skin, a small but significant change. In contrast,
expression of Hoxc13 was decreased to 10% of that seen in
control skin by CtBP1 transgene expression (Figure 6a).
Figure 6b illustrates the decrease in Gata3 and Hoxc13
expression in hair follicles of K5.CtBP1 mice.
A recent study shows that Dlx3 upregulates the expression
of the inner root sheath–forming keratins (Kim et al., 2012).
Therefore, we measured the levels of Type I inner root sheath
keratin genes Krt25, Krt27, and Krt28 and Type II inner root
sheath keratin gene Krt71 in wild-type and K5.CtBP1 skin.
Similar to the decrease in Hoxc13 expression observed in
K5.CtBP1 skin, the mRNA levels of Krt25, Krt27, and Krt28
decreased significantly when compared with control skin
(Figure 6c). The expression of Krt71 was decreased by 4-fold
as well (Figure 6c). Taken together, these findings indicate that
CtBP1 overexpression triggered a downregulation of transcrip-
tion factors and hair keratins critical for the maintenance of
hair follicle homeostasis.
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Figure 3. Aberrant differentiation in the epidermis and hair follicles of K5.CtBP1 skin. (a) Downregulation of CtBP1 target gene E-cadherin in K5.CtBP1 skin.
**Po0.01. (b) Immunofluorescence staining for E-cadherin (green) shows significant loss of E-cadherin in K5.CtBP1 epidermis and hair follicles. Keratin 14 (red)
was used as a counterstain. Scale bar¼ 40mm. (c) Immunofluorescence staining (green) for differentiation markers loricrin and filaggrin shows loss of these
proteins in the K5.CtBP1 epidermis. Keratin 14 (red) was used as a counterstain. Scale bar¼ 40mm. (d) Western blotting of loricrin and filaggrin in wild-type (WT)
and K5.CtBP1 skin. Keratin 14 (K14) serves as a loading control. (e) qRT–PCR analysis of the differentiation marker genes loricrin and filaggrin in K5.CtBP1 skins.
NS, no statistical significance by Student’s t test.
H Deng et al.
CtBP1 Induces Skin Abnormalities
www.jidonline.org 1327
DISCUSSION
Epidermal E-cadherin loss, hyperproliferation, and poor
differentiation are caused by keratinocyte-specific CtBP1
overexpression
We and others have shown that CtBP1 expression can be
reinitiated in cancers (Nadauld et al., 2006; Deng et al.,
2010); thus, we studied whether pathologically induced CtBP1
overexpression perturbs skin homeostasis. Consistent with
previous in vitro studies, we found hyperproliferation, down-
regulated differentiation, and loss of E-cadherin in K5.CtBP1
mouse skin. Among potential CtBP1 targets associated with
proliferation, we found downregulation of p21 and Brca1.
Increased proliferation can be, but is not always, associated
with reduced differentiation. Both p21 and Brca1 inhibit cell
cycle progression and induce differentiation in the epidermis
(Missero et al., 1996; Berton et al., 2003). Therefore, reduced
p21 and Brca1 could contribute to reduced differentiation of
K5.CtBP1 epidermis. We also found gradual E-cadherin loss
in the transgenic epidermis and hair follicles. Keratinocyte-
specific E-cadherin knockout mice do not show epidermal
blisters but display epidermal hyperproliferation and poor
differentiation in both the epidermis and hair follicles (Young
et al., 2003; Tinkle et al., 2004). Thus, E-cadherin loss in
K5.CtBP1 transgenic mice could significantly contribute to
progressive hyperplasia and poor terminal differentiation.
Dlx3 ablation in keratinocytes has been shown to induce
hyperplasia of the epidermis (Hwang et al., 2008). In the
current study, we found that CtBP1 suppresses transcription of
the Dlx3 gene, which may shift the balance between
proliferation and differentiation and contribute to the overly
proliferative phenotype of the K5.CtBP1 mice. In addition, the
resultant downregulation of Gata3 may further facilitate
overproliferation because Gata3 ablation in the epidermis
has been shown to induce epidermal hyperplasia (Kurek et al.,
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Figure 4. CtBP1 suppresses Dlx3 gene expression in K5.CtBP1 skins.
(a) Hematoxylin and eosin (H&E) staining of wild-type (WT) and K5.CtBP1 hair
shaft and bulb. Scale bar¼ 15mm. Note the reduced hair bulbs in the
transgenic mice. (b) Immunofluorescence staining of Dlx3 (green) shows its
aberrant expression pattern in K5.CtBP1 hair follicles. Keratin 14 (red) was used
as a counterstain. Scale bar¼15mm. (c) Cross-sectional immunofluorescence
staining of Dlx3 (green) and CtBP1 (blue) shows the decreased Dlx3 expression
with CtBP1 expansion to the inner root sheath (IRS) in K5.CtBP1 hair follicles.
ORS, outer root sheath. Keratin 14 (red) was used as a counterstain. Scale
bar¼ 5mm.
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2007). Therefore, keratinocyte proliferation and reduced
differentiation of cells in the epidermis and hair follicles
appear to be critically regulated by CtBP1, as seen from the
synergistic actions of p21, E-cadherin, and terminal differ-
entiation regulators of the epidermis and hair follicles such as
Dlx3 and Gata3.
CtBP1 transcriptionally represses the Dlx3 gene, a critical
regulator of hair follicle differentiation
In our K5.CtBP1 transgenic model, we unexpectedly found
defective hair morphogenesis caused by CtBP1 overexpression
in keratinocytes. Previous studies have shown that Dlx3 is
a transcriptional activator and has a critical role in the
development of the epidermis, hair, bone, and placenta
(Morasso et al., 1996; Feledy et al., 1999; Morasso et al.,
1999; Hassan et al., 2004; Hwang et al., 2008), and Dlx3
mutations are responsible for the defects in hair, teeth, and
bone development called the Tricho-Dento-Osseous
syndrome (Price et al., 1998a, b). Our transgenic mice
displayed hair follicle differentiation abnormalities similar to
K14.Dlx3 / mice, with smaller hair bulbs, reduced
keratinized medulla, and defects in the inner root sheath
and hair shaft (Hwang et al., 2008). Although the hair loss
seems regional, abnormal hair follicles were also observed
where hair was retained (not shown), suggesting that
mechanical triggers, such as rubbing, facilitate hair loss.
Unlike the genetically engineered mice with Dlx3 ablation
in the epidermis in which the Wnt and bone morphogenic
protein signaling pathways are disturbed, the Wnt and bone
morphogenic protein signaling pathways were not perturbed
by CtBP1 overexpression in keratinocytes, presumably
reflecting an incomplete shutdown of Dlx3 in K5.CtBP1
mice. Preservation of the bone morphogenic protein and
Wnt signaling is consistent with the ability of K5.CtBP1 mice
to regenerate hair despite their abnormal hair formation.
Consistent with Dlx3-mediated effects in hair follicles,
keratinocyte-specific overexpression of CtBP1 caused a
decrease in Gata3 and Hoxc13, transcription factors involved
in hair differentiation (Godwin and Capecchi, 1998;
Tkatchenko et al., 2001), and in Type I/II keratins. A
previous study has shown that HOXC13 regulates human
hair keratin gene expression (Jave-Suarez et al., 2002). The
inner root sheath forms its structure by obligate hetero-
dimerization of the specified keratins. Type I inner root
sheath keratin genes Krt25, Krt27, and Krt28 and Type II
inner root sheath keratin gene Krt71 are specifically expressed
in all three layers of the inner root sheath and support the
structure (Runkel et al., 2006; Tanaka et al., 2007). We
observed that expression of these inner root sheath keratins
was downregulated by CtBP1. As a result of keratin loss, the
heterodimer may be reduced, hindering inner root sheath
formation and resulting in further hair abnormality. For
instance, mutations in the helix termination motif of mouse
Type I inner root sheath keratin genes have been shown to
impair the assembly of keratin intermediate filament (Tanaka
et al., 2007). The ability to downregulate both Type I and Type
II keratins may further impair the inner root sheath formation.
In addition to the critical role of Dlx3 in hair follicle
differentiation, ablation of E-cadherin in keratinocytes has
been shown to induce the progressive loss of hair follicle
integrity (Young et al., 2003; Tinkle et al., 2004). We reason
that CtBP1 contributes to hair follicle abnormality through
multiple targets, including Dlx3 and E-cadherin, and thus it
may become more pronounced with aging. Future studies
using an inducible model will help elucidate the impact of
CtBP1 overexpression on epidermal and hair follicle
differentiation at later stages. This model will also allow us
to assess the role of CtBP1 in other pathological processes
such as wound healing.
In summary, we report the CtBP1 transgenic mouse model
to reveal in vivo CtBP1 transcriptional targets in keratinocytes
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decreased to 0.35±0.07 and Hoxc13 mRNA decreased to 0.11±0.06 in
transgenic skin. **Po0.01. (b) Immunofluorescence staining (green) of Gata3
and Hoxc13 shows decreased expression in K5.CtBP1 hair follicles compared
with WT follicles. Keratin 14 (red) was used as a counterstain. Scale
bar¼ 15mm. (c) WT and K5.CtBP1 skins were used for qRT–PCR Keratin 25
(KRT25), keratin 27 (KRT27), keratin 28 (KRT28), and keratin 71 (KRT71)
mRNA expression levels. Error bars indicate SD (n¼3), and significance was
determined using Student’s t test. **Po0.01.
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and functions associated with epidermal hyperproliferation,
reduced differentiation, and E-cadherin downregulation.
Further, CtBP1 has a role in hair morphogenesis, which had
not been identified previously, and can only be appreciated
with CtBP1 overexpression during differentiation of the hair
follicle. Our data instigate future studies to determine whether
pathologically induced CtBP1 overexpression has a role in
skin pathogenesis in human diseases.
MATERIALS AND METHODS
Generation and identification of K5.CtBP1 mice
All animal experiments were performed with the approval of IACUC
at the University of Colorado Denver. The 1.3 kb full-length wild-type
human CtBP1 cDNA was inserted into the K5 expression vector (He
et al., 2002). K5.CtBP1 transgenic mice were generated with the
B6D2 strain by microinjection of the transgene into the pronuclei of
mouse embryos. Mice were genotyped by PCR analysis of tail DNA
using primers specific for BK5 (tctgataggcagcctgcacc) and CtBP1
(atcccagctgctgtggaagg). Throughout this study, all transgenic mice
were heterozygous; all wild-type mice were littermates, and at least
three independent analyses were performed for each assay, using
three to five samples in each group.
Tissue histology, immunofluorescence, immunohistochemistry,
western blotting, and in situ hybridization
Skin histology was visualized with hematoxylin and eosin (H&E)
staining. Immunofluorescence, immunohistochemistry, and western
blotting were performed on frozen and paraffin-embedded sections as
previously described (Wang et al., 1999). Immunofluorescence and
western blotting were performed using antibodies against CtBP1
(Millipore, Billerica, MA), loricrin, filaggrin (Covance, San Diego,
CA), Hoxc13 (Abnova, Walnut, CA), Gata3 (Santa Cruz, Santa Cruz,
CA), E-cadherin (BD Biosciences, San Jose, CA), Dlx3 (Abcam,
Cambridge, MA), and Keratin 14 (Fitzgerald, Acton, MA). The
antibodies used in immunohistochemical analysis included CtBP1
(Millipore) and PCNA (Santa Cruz). For immuno-
fluorescence, secondary antibodies to different species IgG were
Alexa Fluor 594 (red) or 488 (green) conjugated (1:200 for all,
Invitrogen, Grand Island, NY). For immunohistochemical analysis,
we used secondary biotinylated antibodies to different species IgG
(1:300, Vector Labs, Burlingame, CA) and developed using Vectastain
ABC kit (Vector Labs). In situ hybridization with antisense
digoxigenin-UTP-labeled RNA probes on sections of skin samples
was performed as described (Han et al., 2006).
Quantitative real-time reverse-transcriptase–PCR
Total RNA was isolated using TRIzol (Invitrogen) as previously
described (Zhang et al., 2006). One hundred nanograms of RNA
from each sample were subjected to quantitative real-time reverse-
transcriptase–PCR (ThermoFisher, Waltham, MA). An 18S probe was
used as an internal control. Each sample was examined in triplicate.
The relative RNA expression levels were determined by normalizing
with internal controls, the values of which were calculated using the
comparative Ct method.
Cell culture and transfections
Mouse keratinocytes were isolated from neonatal mouse skin as
previously described (Han et al., 2011), and cultured in PCT medium
(CELLnTEC, Bern, Switzerland). Fadu, a human HNSCC line, was
purchased from ATCC and cultured in DMEM with 10% fetal bovine
serum. To knock down CtBP1, cells were treated with siRNA against
CtBP1 from Dharmacon (Lafayette, CO) using Lipofectamine 2000
(Invitrogen) for 48hours and then collected. Keratinocytes were treated
with BrdU; cells that incorporated BrdU were stained by FITC anti-BrdU.
ChIP and luciferase reporter assay
Keratinocytes were transfected with a CtBP1-expressing vector, either
wild-type or the PLDLX-binding deficient mutant tagged with FLAG
epitope. ChIP assay was performed with an anti-FLAG antibody as
described previously (Zhang et al., 2006). Primer sets spanning the
Dlx3 promoter were used to quantitative reverse transcriptase in real-
time-amplify the ChIP sample. The pGL4.26 DLX3 promoter luci-
ferase reporter plasmid was generated by cloning a PCR-amplified
 286 to 0 bp fragment of the Dlx3 promoter into the XhoI and NheI
sites of the pGL4.26 vector (Promega, Madison, WI). Dlx3 promoter–
specific primers used were 50-TATCTCGAGCCGCACAGCCAAC-30
(forward) and 50-AATGCTAGCGCCAGCTCCGCCC-30 (reverse). An
empty renilla luciferase vector (pGL4.79) was used for normalization.
Mouse keratinocytes were co-transfected with the reporters and
CtBP1-expressing plasmids for 48 hours and luciferase activity was
measured (Zhang et al., 2002). Human Fadu cells were co-transfected
with the reporters and siRNA to CtBP1 for 48 hours and luciferase
activity was measured (Zhang et al., 2002). Scrambled siRNA or
empty plasmid was used for controls.
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